Related Experiment Video
Updated: May 24, 2025

Cardiac Response to β-Adrenergic Stimulation Determined by Pressure-Volume Loop Analysis
Published on: May 19, 2021
Coupling Interval Ratio to Predict the Beta-Blocker Response Against Premature Ventricular Complexes.
1Türkiye Hospital Division of Cardiology, Istanbul, Turkey.
Predicting beta-blocker response in premature ventricular complexes (PVCs) is crucial. Shorter coupling intervals (CI) during nighttime Holter monitoring can predict a positive response to beta-blocker therapy for PVCs.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Beta-blockers are widely used for premature ventricular complexes (PVCs) but exhibit unpredictable efficacy.
- Identifying predictors of beta-blocker response is essential for optimizing treatment of PVCs.
- Holter-guided electrocardiographic criteria may offer insights into treatment responsiveness.
Purpose of the Study:
- To identify Holter-guided electrocardiographic criteria that predict beta-blocker responsiveness in patients with PVCs.
- To evaluate the association between heart rate variability, coupling intervals (CIs), and beta-blocker treatment outcomes for PVCs.
Main Methods:
- Retrospective analysis of 89 patients with pre- and post-treatment Holter electrocardiogram recordings.
- Screening of Holter recordings for heart rate variability, PVC burden, heart rate, and pre- and post-coupling intervals (CIs) across three time intervals.
- Definition of beta-blocker responders based on a 70% decrease in PVC burden.
Main Results:
- No statistically significant differences in heart rate variability between responder and non-responder groups.
- A statistically significant difference in CI ratio between groups during the 24:00-08:00 am interval (3.19 vs. 2.91, P = 0.006).
- Nighttime increased CI ratio (shorter CI time) was an independent predictor of beta-blocker response for PVCs (OR, 9.54; P = 0.006).
Conclusions:
- Nighttime coupling interval ratio is a significant predictor of beta-blocker responsiveness in PVCs.
- Beta-blockers may be particularly beneficial for patients with PVCs exhibiting shorter nighttime CIs or increased nighttime CI ratios.
- Holter-guided CI analysis can aid in tailoring beta-blocker therapy for PVC management.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Correlation between ECG and Cardiac Cycle
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...
Heart Failure Drugs: β-Blockers
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...